In A549 (AT2; alveolar cell type II phenotype lung cancer cell), TGF-β1 treatment induced myofibroblast marker and CSF3 expression, but surfactant protein expression was reduced, which was restored by FB-101 treatment (Supplementary Fig. 12a). Here, TGFB1 is linked to lung cancer.